3-[4-[[2-[[4-[(2R)-1-cyclohexylpyrrolidin-2-yl]-1,3-thiazol-2-yl]carbamoyl]pyrrol-1-yl]methyl]-2-pyridinyl]-N-[4-[(Z)-2-pyridazin-3-ylethenyl]-1,3-thiazol-2-yl]-1-(pyridin-4-ylmethyl)pyrrole-2-carboxamide

C44H43N11O2S2 — CID 154695287

IUPAC3-[4-[[2-[[4-[(2R)-1-cyclohexylpyrrolidin-2-yl]-1,3-thiazol-2-yl]carbamoyl]pyrrol-1-yl]methyl]-2-pyridinyl]-N-[4-[(Z)-2-pyridazin-3-ylethenyl]-1,3-thiazol-2-yl]-1-(pyridin-4-ylmethyl)pyrrole-2-carboxamide
SMILESO=C(Nc1nc([C@H]2CCCN2C2CCCCC2)cs1)c1cccn1Cc1ccnc(-c2ccn(Cc3ccncc3)c2C(=O)Nc2nc(/C=C\c3cccnn3)cs2)c1
InChIInChI=1S/C44H43N11O2S2/c56-41(50-44-49-37(29-59-44)38-10-6-23-55(38)34-8-2-1-3-9-34)39-11-5-22-53(39)27-31-16-21-46-36(25-31)35-17-24-54(26-30-14-19-45-20-15-30)40(35)42(57)51-43-48-33(28-58-43)13-12-32-7-4-18-47-52-32/h4-5,7,11-22,24-25,28-29,34,38H,1-3,6,8-10,23,26-27H2,(H,48,51,57)(H,49,50,56)/b13-12-/t38-/m1/s1
InChIKeyOHDDZBWBOLWOLE-PGIFZVEJSA-N
MW822.04 g/mol
LogP8.69
Rot. Bonds13

About 3-[4-[[2-[[4-[(2R)-1-cyclohexylpyrrolidin-2-yl]-1,3-thiazol-2-yl]carbamoyl]pyrrol-1-yl]methyl]-2-pyridinyl]-N-[4-[(Z)-2-pyridazin-3-ylethenyl]-1,3-thiazol-2-yl]-1-(pyridin-4-ylmethyl)pyrrole-2-carboxamide

3-[4-[[2-[[4-[(2R)-1-cyclohexylpyrrolidin-2-yl]-1,3-thiazol-2-yl]carbamoyl]pyrrol-1-yl]methyl]-2-pyridinyl]-N-[4-[(Z)-2-pyridazin-3-ylethenyl]-1,3-thiazol-2-yl]-1-(pyridin-4-ylmethyl)pyrrole-2-carboxamide (PubChem CID 154695287) has the molecular formula C44H43N11O2S2 and a molecular weight of 822.04 g/mol. Its IUPAC name is 3-[4-[[2-[[4-[(2R)-1-cyclohexylpyrrolidin-2-yl]-1,3-thiazol-2-yl]carbamoyl]pyrrol-1-yl]methyl]-2-pyridinyl]-N-[4-[(Z)-2-pyridazin-3-ylethenyl]-1,3-thiazol-2-yl]-1-(pyridin-4-ylmethyl)pyrrole-2-carboxamide.

Molecular Properties

Compound Name3-[4-[[2-[[4-[(2R)-1-cyclohexylpyrrolidin-2-yl]-1,3-thiazol-2-yl]carbamoyl]pyrrol-1-yl]methyl]-2-pyridinyl]-N-[4-[(Z)-2-pyridazin-3-ylethenyl]-1,3-thiazol-2-yl]-1-(pyridin-4-ylmethyl)pyrrole-2-carboxamide
PubChem CID154695287
Molecular FormulaC44H43N11O2S2
Molecular Weight822.04 g/mol
Exact Mass821.30
IUPAC Name3-[4-[[2-[[4-[(2R)-1-cyclohexylpyrrolidin-2-yl]-1,3-thiazol-2-yl]carbamoyl]pyrrol-1-yl]methyl]-2-pyridinyl]-N-[4-[(Z)-2-pyridazin-3-ylethenyl]-1,3-thiazol-2-yl]-1-(pyridin-4-ylmethyl)pyrrole-2-carboxamide
SMILESO=C(Nc1nc([C@H]2CCCN2C2CCCCC2)cs1)c1cccn1Cc1ccnc(-c2ccn(Cc3ccncc3)c2C(=O)Nc2nc(/C=C\c3cccnn3)cs2)c1
InChIInChI=1S/C44H43N11O2S2/c56-41(50-44-49-37(29-59-44)38-10-6-23-55(38)34-8-2-1-3-9-34)39-11-5-22-53(39)27-31-16-21-46-36(25-31)35-17-24-54(26-30-14-19-45-20-15-30)40(35)42(57)51-43-48-33(28-58-43)13-12-32-7-4-18-47-52-32/h4-5,7,11-22,24-25,28-29,34,38H,1-3,6,8-10,23,26-27H2,(H,48,51,57)(H,49,50,56)/b13-12-/t38-/m1/s1
InChIKeyOHDDZBWBOLWOLE-PGIFZVEJSA-N
XLogP8.69
TPSA148.64 Ų
H-Bond Donors2
H-Bond Acceptors13
Rotatable Bonds13
Heavy Atoms59
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500822.04
LogP ≤ 58.69
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1013

Analyze 3-[4-[[2-[[4-[(2R)-1-cyclohexylpyrrolidin-2-yl]-1,3-thiazol-2-yl]carbamoyl]pyrrol-1-yl]methyl]-2-pyridinyl]-N-[4-[(Z)-2-pyridazin-3-ylethenyl]-1,3-thiazol-2-yl]-1-(pyridin-4-ylmethyl)pyrrole-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[4-[[2-[[4-[(2R)-1-cyclohexylpyrrolidin-2-yl]-1,3-thiazol-2-yl]carbamoyl]pyrrol-1-yl]methyl]-2-pyridinyl]-N-[4-[(Z)-2-pyridazin-3-ylethenyl]-1,3-thiazol-2-yl]-1-(pyridin-4-ylmethyl)pyrrole-2-carboxamide?
The IUPAC name of 3-[4-[[2-[[4-[(2R)-1-cyclohexylpyrrolidin-2-yl]-1,3-thiazol-2-yl]carbamoyl]pyrrol-1-yl]methyl]-2-pyridinyl]-N-[4-[(Z)-2-pyridazin-3-ylethenyl]-1,3-thiazol-2-yl]-1-(pyridin-4-ylmethyl)pyrrole-2-carboxamide (CID 154695287) is 3-[4-[[2-[[4-[(2R)-1-cyclohexylpyrrolidin-2-yl]-1,3-thiazol-2-yl]carbamoyl]pyrrol-1-yl]methyl]-2-pyridinyl]-N-[4-[(Z)-2-pyridazin-3-ylethenyl]-1,3-thiazol-2-yl]-1-(pyridin-4-ylmethyl)pyrrole-2-carboxamide.
What is the SMILES notation for 3-[4-[[2-[[4-[(2R)-1-cyclohexylpyrrolidin-2-yl]-1,3-thiazol-2-yl]carbamoyl]pyrrol-1-yl]methyl]-2-pyridinyl]-N-[4-[(Z)-2-pyridazin-3-ylethenyl]-1,3-thiazol-2-yl]-1-(pyridin-4-ylmethyl)pyrrole-2-carboxamide?
The canonical SMILES for 3-[4-[[2-[[4-[(2R)-1-cyclohexylpyrrolidin-2-yl]-1,3-thiazol-2-yl]carbamoyl]pyrrol-1-yl]methyl]-2-pyridinyl]-N-[4-[(Z)-2-pyridazin-3-ylethenyl]-1,3-thiazol-2-yl]-1-(pyridin-4-ylmethyl)pyrrole-2-carboxamide is O=C(Nc1nc([C@H]2CCCN2C2CCCCC2)cs1)c1cccn1Cc1ccnc(-c2ccn(Cc3ccncc3)c2C(=O)Nc2nc(/C=C\c3cccnn3)cs2)c1.
What is the InChIKey of 3-[4-[[2-[[4-[(2R)-1-cyclohexylpyrrolidin-2-yl]-1,3-thiazol-2-yl]carbamoyl]pyrrol-1-yl]methyl]-2-pyridinyl]-N-[4-[(Z)-2-pyridazin-3-ylethenyl]-1,3-thiazol-2-yl]-1-(pyridin-4-ylmethyl)pyrrole-2-carboxamide?
The InChIKey is OHDDZBWBOLWOLE-PGIFZVEJSA-N. The full InChI is InChI=1S/C44H43N11O2S2/c56-41(50-44-49-37(29-59-44)38-10-6-23-55(38)34-8-2-1-3-9-34)39-11-5-22-53(39)27-31-16-21-46-36(25-31)35-17-24-54(26-30-14-19-45-20-15-30)40(35)42(57)51-43-48-33(28-58-43)13-12-32-7-4-18-47-52-32/h4-5,7,11-22,24-25,28-29,34,38H,1-3,6,8-10,23,26-27H2,(H,48,51,57)(H,49,50,56)/b13-12-/t38-/m1/s1.
What are the key properties of 3-[4-[[2-[[4-[(2R)-1-cyclohexylpyrrolidin-2-yl]-1,3-thiazol-2-yl]carbamoyl]pyrrol-1-yl]methyl]-2-pyridinyl]-N-[4-[(Z)-2-pyridazin-3-ylethenyl]-1,3-thiazol-2-yl]-1-(pyridin-4-ylmethyl)pyrrole-2-carboxamide?
3-[4-[[2-[[4-[(2R)-1-cyclohexylpyrrolidin-2-yl]-1,3-thiazol-2-yl]carbamoyl]pyrrol-1-yl]methyl]-2-pyridinyl]-N-[4-[(Z)-2-pyridazin-3-ylethenyl]-1,3-thiazol-2-yl]-1-(pyridin-4-ylmethyl)pyrrole-2-carboxamide has a molecular weight of 822.04 g/mol, XLogP of 8.69, 13 rotatable bonds, 2 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[4-[[2-[[4-[(2R)-1-cyclohexylpyrrolidin-2-yl]-1,3-thiazol-2-yl]carbamoyl]pyrrol-1-yl]methyl]-2-pyridinyl]-N-[4-[(Z)-2-pyridazin-3-ylethenyl]-1,3-thiazol-2-yl]-1-(pyridin-4-ylmethyl)pyrrole-2-carboxamide is sourced from PubChem (CID 154695287), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).